CV | tickerfilter.com

Fundamental analysis

36%

Profitability 35%

Dept financing 28%

Liquidity 71%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.99%

1 Month

-33.60%

3 Months

-1.87%

6 Months

17.76%

1 Year

64.86%

2 Year

64.86%

Key data

Stock price

$5.77

P/E Ratio

N/A

DAY RANGE

$5.61 - $6.01

EPS

-$0.17

52 WEEK RANGE

$3.43 - $15.37

52 WEEK CHANGE

$64.86

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$125,147

AVERAGE 30 VOLUME

$173,369

Company detail

CEO: Kang-Huai Wang
Region: US
Website: capsovision.com
Employees: 90
IPO year: 2006

Issue type:
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

We are a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in our capsule endoscopy solutions to identify abnormalities of the gastrointestinal (“GI”) tract for diagnostic and screening purposes. We were incorporated under the laws of the State of Delaware on August 1, 2005, under the name “Capso Vision, Inc.” and changed our name to CapsoVision, Inc. on May 31, 2016. Our principal executive office is located in Saratoga, CA.

CV - CapsoVision Inc.